How a three-pronged IP strategy could help biosimilar manufacturers
Biosimilar manufacturers should assess the patent portfolios of third parties, determine whether they can obtain patent protection of their own, and identify opportunities for licensing, to take advantage of the opportunities for growth in the market in the years ahead.
